Phumla Sinxadi, MBChB, MMed, PhD

Chief Medical Officer

  • A/Prof Phumla Sinxadi is a consultant clinical pharmacologist, as well as an Associate Professor of  Medicine in the Division of Clinical Pharmacology, University of Cape Town (UCT), South Africa 

  • Phumla teaches clinical pharmacology to undergraduate and postgraduates students at UCT. Her  main research interests include i) pharmacokinetics and pharmacogenomics of antiretroviral  drugs; ii) gene-gene interactions between antiretroviral and antituberculous drugs, iii) drug  development. She was the lead investigator for the First-in-Man clinical trial investigating the safety,  tolerability and pharmacokinetics of MMV390048, a novel antimalarial drug discovered at UCT. 1st  African First Into Human study for an antimalarial compound for an African led international  collaborative project.  

  • She received her PhD degree in Clinical Pharmacology from the University of Cape Town in 2016, a  Masters of Medicine in Clinical Pharmacology in 2010, and a Bachelor of Medicine and Surgery  degree in 2001. In 2017, she completed a Certificate in Human Pharmacology from the Faculty of  Pharmaceutical Medicine of the Royal College of Physicians in the United Kingdom.  

  • After completing her PhD, she spent a year at GlaxoSmithKline (London) as a WHO-TDR Career  Development Fellow